309 related articles for article (PubMed ID: 7740406)
1. [The results of primary HDR-afterloading brachytherapy in corpus carcinoma].
Knocke TH; Kucera H; Weidinger B; Höller W; Pötter R
Strahlenther Onkol; 1995 Apr; 171(4):195-201. PubMed ID: 7740406
[TBL] [Abstract][Full Text] [Related]
2. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
3. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
4. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
6. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
[TBL] [Abstract][Full Text] [Related]
7. Treatment of endometrial carcinoma with high-dose-rate brachytherapy alone in medically inoperable stage I patients.
Kucera H; Knocke TH; Kucera E; Pötter R
Acta Obstet Gynecol Scand; 1998 Nov; 77(10):1008-12. PubMed ID: 9849846
[TBL] [Abstract][Full Text] [Related]
8. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
9. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results.
Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
Strahlenther Onkol; 1994 Nov; 170(11):636-42. PubMed ID: 7974179
[TBL] [Abstract][Full Text] [Related]
11. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.
Röper B; Astner ST; Heydemann-Obradovic A; Thamm R; Jacob V; Hölzel D; Schmalfeldt B; Kiechle-Bahat M; Höss C; Molls M
Gynecol Oncol; 2007 Dec; 107(3):541-8. PubMed ID: 17884152
[TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
13. [Endometrial adenocarcinoma treated with combined radiotherapy and surgery: 437 cases].
Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Ginesty C; Ganansia V; Jamali M; Milliez J; Blondon J; Schlienger M
Cancer Radiother; 2001 Aug; 5(4):425-44. PubMed ID: 11521391
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate brachytherapy as the primary treatment of medically inoperable stage I-II endometrial carcinoma.
Nguyen C; Souhami L; Roman TN; Clark BG
Gynecol Oncol; 1995 Dec; 59(3):370-5. PubMed ID: 8522257
[TBL] [Abstract][Full Text] [Related]
15. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
[TBL] [Abstract][Full Text] [Related]
16. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
17. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma.
Niazi TM; Souhami L; Portelance L; Bahoric B; Gilbert L; Stanimir G
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1108-13. PubMed ID: 16099598
[TBL] [Abstract][Full Text] [Related]
19. Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy.
Pai HH; Souhami L; Clark BG; Roman T
Gynecol Oncol; 1997 Aug; 66(2):300-7. PubMed ID: 9264580
[TBL] [Abstract][Full Text] [Related]
20. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
